Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AgileNano is a nanotechnology company focused on the development and commercialization of advanced antimicrobial surface technologies. A spin-out from the University of Nottingham, the company leverages proprietary surface engineering techniques to create coatings that rapidly eliminate bacteria, viruses, and fungi upon contact. Their core technology, NitroPep, is designed for application on high-touch surfaces in healthcare settings, public transportation, and industrial environments to reduce the transmission of infectious diseases. By permanently bonding antimicrobial agents to various substrates, AgileNano provides a long-lasting solution to healthcare-associated infections without the risk of environmental leaching. The company's work sits at the intersection of materials science and public health, aiming to improve hygiene standards globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AgileNano.